DHR vs IDXX — Key Metrics

Metric DHR (DANAHER CORP) IDXX (IDEXX LABORATORIES INC)
Price228.58698.47
Market Cap160.81 Billion55.03 Billion
P/E (TTM)37.3546.81
P/B (Quarterly)3.06828.31
P/S (TTM)6.2811.8
Net Profit Margin (TTM)16.925.4
Gross Margin (TTM)58.662.7
ROE (TTM)8.271.2
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

DANAHER CORP
vs
 
IDEXX LABORATORIES INC
 
DANAHER CORP
vs
 
IDEXX LABORATORIES INC
Performance Comparison
AI Model Recommendation
DHR · DANAHER CORP

Underperform

-49
UnderperformOutperform
IDXX · IDEXX LABORATORIES INC

Greatly Underperform

-98
UnderperformOutperform
Recommendation Summary

Stock DHR is projected to underperform the market, stock IDXX is projected to greatly underperform the market. Upfront Recommendation: DHR.

Financial Metrics
Prices delayed ~15 min
DHR Metrics IDXX
$228.58 Price $698.47
— Market Capitalization —
37.35 Price to Earnings Ratio 46.81
6.28 Price to Sales 11.8
27.96 Price to FCF Ratio 42.65
10.72 Price to Gross Profit 18.82
96.3 Price to R&D 206.21
10.88 Price to Current Assets 36.69

DHR vs IDXX at a glance

Danaher Corp (DHR) and Idexx Laboratories INC (IDXX) are both Diagnostics & Research companies in the Healthcare sector. DHR is the larger, at $160.8 billion in market value against $55.0 billion for IDXX, about 2.9 times the size.

On trailing-twelve-month figures, DHR trades at 37.4 times trailing earnings and IDXX at 46.8; net profit margins are 16.9% and 25.4%.

The Upfront Investment model currently rates DHR Underperform and IDXX Greatly Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.